Search Results - "Dumont, Nicole"
-
1
Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial
Published in Journal of the American Academy of Dermatology (01-06-2020)Get full text
Journal Article -
2
Concomitant atopic dermatitis and psoriasis - a retrospective review
Published in The Journal of dermatological treatment (03-10-2021)“…At one time considered opposing diseases, it is now recognized that atopic dermatitis (AD) and psoriasis can coexist. There are limited data characterizing…”
Get full text
Journal Article -
3
Exploiting semantic information in a spiking neural SLAM system
Published in Frontiers in neuroscience (05-07-2023)“…To navigate in new environments, an animal must be able to keep track of its position while simultaneously creating and updating an internal map of features in…”
Get full text
Journal Article -
4
Optimal Pricing of Climate Risk
Published in Computational economics (01-10-2022)“…The climate change model of Daniel et al. (Proc Natl Acad Sci USA 116(42):20886-20891, 2019. https://doi.org/10.1073/pnas.1817444116) is an important…”
Get full text
Journal Article -
5
Biologically-Based Computation: How Neural Details and Dynamics Are Suited for Implementing a Variety of Algorithms
Published in Brain sciences (31-01-2023)“…The Neural Engineering Framework (Eliasmith & Anderson, 2003) is a long-standing method for implementing high-level algorithms constrained by low-level…”
Get full text
Journal Article -
6
Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease
Published in Pediatric dermatology (01-11-2013)“…Adults with psoriasis have a greater risk of developing metabolic syndrome (MetS) and cardiovascular disease (CVD), but few studies have investigated the…”
Get full text
Journal Article -
7
Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skin
Published in Journal of dermatological science (01-06-2016)Get full text
Journal Article -
8
A retrospective review of dupilumab and psoriasis biologic combination therapy
Published in The Journal of dermatological treatment (19-05-2021)Get full text
Journal Article -
9
A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis
Published in Journal of the American Academy of Dermatology (01-04-2019)Get full text
Journal Article -
10
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
Published in Journal of the American Academy of Dermatology (01-06-2017)“…Background Existing therapies for vitiligo are limited in efficacy and can be associated with undesirable side effects. Topical Janus kinase inhibitors may…”
Get full text
Journal Article -
11
Dupilumab as a Treatment for Allergic Contact Dermatitis
Published in Dermatitis (01-11-2018)Get more information
Journal Article -
12
-
13
-
14
-
15
CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial
Published in JAMA dermatology (Chicago, Ill.) (01-08-2015)“…Methotrexate is a first-line systemic agent for treating of psoriasis, although its onset of effects is slower and overall it is less effective than tumor…”
Get more information
Journal Article -
16
Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review
Published in Dermatitis (01-11-2021)Get more information
Journal Article -
17
Continuation and Discontinuation Rates of Biologics in Dermatology Patients During COVID-19 Pandemic
Published in Journal of cutaneous medicine and surgery (01-11-2021)Get full text
Journal Article -
18
Results of Switching From Tofacitinib to Upadacitinib in Patients With Atopic Dermatitis: A Retrospective Medical Record Review
Published in Dermatitis (01-11-2021)Get more information
Journal Article -
19
Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review
Published in Journal of drugs in dermatology (01-08-2015)“…No systemic drugs are approved by the Food and Drug Administration to treat pediatric psoriasis due to a lack of supporting data. The purpose of this study is…”
Get more information
Journal Article -
20
A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis
Published in Journal of drugs in dermatology (01-03-2012)“…Evaluate the efficacy and safety of apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, in subjects with recalcitrant moderate to severe atopic…”
Get more information
Journal Article